This story is most useful when read as a ai at work signal, not as a one-off viral claim. The important question is what changes for users, teams, or product strategy once the initial announcement is put in context.
- Workplace AI impact is task-specific and varies by role, policy, and adoption quality.
- Productivity claims need evidence from real teams, not only demos or funding signals.
- The strongest implementations combine AI assistance with clear human accountability.
For more context, see the AI at Work section.
The $650B AI spend has a margin problem nobody wants to admit
Enterprise AI budgets are exploding. Gartner forecasts enterprise software spend will rise at least 40% by 2027, with global spending on AI-enabled apps hitting $644 billion in 2025—up 76.4% year-over-year. But the tools capturing that spend are structurally unprofitable.
Here’s why: scaling AI SaaS from pilot to production reveals 500–1,000% cost underestimations, according to BetterCloud data. Inference costs devour margins faster than founders can raise capital. AI add-ons jack up base SaaS prices by 30–110%—Microsoft Copilot alone commands a 60–70% premium. With AI adoption across enterprises hitting 80% by end of 2026, up from under 5% pre-2024, the pressure to prove unit economics has never been higher.
VCs now demand one thing upfront: LTV greater than CAC without another funding round. Most horizontal tools can’t deliver that math. The SaaSpocalypse trend shows horizontal SaaS collapsing as AI agents erode per-seat models—and investors are reallocating capital before the bodies pile up.
Vertical SaaS just became the only AI bet VCs will take
The money is moving. While everyone assumes AI SaaS is in decline, vertical SaaS hit $94.86 billion in 2026 with 7% funding growth year-over-year, according to Qubit Capital. Healthcare, finance, and aerospace lead with $1.1 billion in vertical AI funding—Databricks closed a $10 billion deal, xAI secured $6 billion.
The thesis is simple: proprietary data moats in regulated industries create defensibility that generic automation can’t match. Healthcare needs HIPAA-compliant workflows. Manufacturing demands real-time supply chain context. Financial services require audit trails that generic tools will never build. VCs want businesses that own workflows, not workflow automation tools that sit on top of someone else’s platform.
And the market is massive. Gartner projects 80% of enterprises will deploy GenAI apps by year-end, but only vertical players with domain context will capture the spend. Ryabenkiy’s firm is “reallocating capital toward businesses that own workflows… away from products that can be copied.” That’s not a trend—it’s a survival filter.
The irony: budgets are growing, but most AI SaaS won’t see it
Enterprise software spend will rise 40% by 2027 due to GenAI, but VCs are cutting off products that can be copied overnight. Generic tools face commoditization as employees are already using AI through free consumer products, making per-seat enterprise pricing harder to defend.
The honest trade-off? Vertical SaaS requires deep domain expertise, longer sales cycles, and sector-specific compliance—barriers that keep most founders out. The TechCrunch article names what’s dead: thin wrappers, generic tools, UI-only automation. But it doesn’t name who died. Because the pivot is happening quietly, before the funding runs out.
Two forces are colliding: the biggest enterprise AI budgets in history versus the narrowest funding criteria VCs have ever imposed. 2026 will separate the vertical players who own workflows from the horizontal tools that become free features in someone else’s platform. No one’s predicting which side wins. They’re just picking sides before the collision.
